Ann: Epichem's New Laboratory Completed, page-98

Aurelius I agree with you, however a major responsibility of Management is to protect shareholder value and to date this hasnt happened.

One simple thing that they could have done here is to advice the market when they received the report and that it was being reviewed.
Along with why there has been no update on canine recruitment as stated by them - "Canine recruitment will continue and the company will continue reporting on the outcomes in canine patients, and
The company will determine the next stages with Options partner (top 5 pharmaceutical company) for the veterinary applications of ppl - 1 and related molecules".

This was reported in July this year and confirmed in the yearly - however no updates.

To me this set an expectation that dogs were still being recruited - this expectation has not be full filled

DYOR